| AMP | 5′-adenosine monophosphate |
| AMPK | AMP-activated protein kinase |
| CMP | 5′-cytimidine monophosphate |
| Control | normal control group |
| CS | citrate synthase |
| CVD | cardiovascular disease |
| DEMs | differentially expressed metabolites |
| GMP | 5′-guanosine monophosphate |
| GSH-Px | glutathione peroxidase |
| HE | hematoxylin-eosin |
| IL-1β | interleukin-1 β |
| IL-6 | interleukin-6 |
| IMP | inosinic acid |
| MDA | malondialdehyde |
| NTs | nucleotides |
| NTs_H | high-dose NTs group |
| NTs_L | low-dose NTs group |
| OPLS-DA | orthogonal projections to latent structures-discriminate analysis |
| OXPHOS | oxidative phosphorylation |
| PCA | principal component analysis |
| PGC-1α | peroxisome proliferator-activated receptor-gamma coactivator-1α |
| ROS | reactive oxygen species |
| SAMP8 | senescence-accelerated mouse prone-8 |
| SAMR1 | senescence-accelerated mouse resistant 1 |
| SDH | succinate dehydrogenase enzyme |
| SOD | superoxide dismutase |
| SPF | specific-pathogen free |
| TFAM | mitochondrial transcription factor A |
| TNF-α | tumor necrosis factor-α |
| UMP | 5′-disodium uridine monophosphate |
| VIP | variable importance in the projection |